S. Owen

Imatinib and altered bone and mineral metabolism.

S. Owen, A. Hatfield, L. Letvak, 2006, The New England journal of medicine.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'

P. Pilot, S. Owen, A. Hatfield, 2007, Nature Medicine.

Epidemiological analysis of second primary malignancies in more than 9500 patients treated with imatinib

P. Pilot, S. Owen, A. Hatfield, 2006, Leukemia.